What is new in the 2024 Chinese guidelines for fatty liver disease?

QR Code

What is new in the 2024 Chinese guidelines for fatty liver disease?

Saved in:

Bibliographic Details
Main Authors:	Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2025-07-01
Series:	Clinical and Molecular Hepatology
Subjects:	metabolic dysfunction-associated steatotic liver disease obesity metabolic syndrome alcohol-related liver disease china
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-1165.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The evolution of international definitions of fatty liver disease and insights into the working definition and features of the 2024 Chinese guideline
by: Li CHEN, et al.
Published: (2025-06-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
by: Xianhua Mao, et al.
Published: (2025-07-01)

Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
by: Francisco Aguirre, et al.
Published: (2025-07-01)

Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease
by: Wenhao Wu, et al.
Published: (2025-07-01)

Interventions targeting the gut-liver axis: A potential treatment strategy for metabolic dysfunction-associated steatotic liver disease
by: Pingping Jin, et al.
Published: (2025-07-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

Dietary characteristics associated with the risk of non‐alcoholic fatty liver disease and metabolic dysfunction‐associated steatotic liver disease in non‐obese Japanese participants: A cross‐sectional study
by: Hirokazu Taniguchi, et al.
Published: (2024-05-01)

Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosis
by: Benedict T.K. Vanlerberghe, et al.
Published: (2025-08-01)

Differential Expression of Lipid Metabolism Genes, CROT and ABCG1, in Obese Patients with Comorbid Depressive Disorder and Risk of MASLD
by: Joanna Michalina Jurek, et al.
Published: (2025-06-01)

Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
by: Weixiong Zhu, et al.
Published: (2025-07-01)

Metabolic and inflammatory links between metabolic dysfunction-associated steatotic liver disease and Alzheimer's disease
by: Gary Zhang
Published: (2025-04-01)

Effect of liver biopsy size on MASLD fibrosis assessment by second-harmonic generation/two-photon excitation fluorescence microscopy
by: Daniel T. Field, et al.
Published: (2025-08-01)

Adaptation using IM Adapt of an evidence-based lifestyle intervention to support the management of metabolic-dysfunction associated steatotic liver disease among Hispanic/Latino adults
by: Natalia I. Heredia, et al.
Published: (2025-07-01)

Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
by: Minkwan Kim, et al.
Published: (2025-07-01)

The Role of "Biotics" in the Modulation of the Intestinal Microbiota in Metabolic-Associated Steatotic Liver Disease
by: G. Fadieienko, et al.
Published: (2025-03-01)

Association of estimated glucose disposal rate with risk of future metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study
by: Yan Li, et al.
Published: (2025-07-01)

Adherence to a “MediterrAsian” diet is associated with weight loss-independent improvements in liver fat and lipid profile, but not glucoregulation or inflammation: secondary analysis of a randomized controlled trial
by: Yu Chung Chooi, et al.
Published: (2025-07-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Non-alcoholic fatty liver disease and metabolic liver dysfunction in the new coronavirus infection COVID-19
by: A. A. Karaseva, et al.
Published: (2021-12-01)

Application of radiofrequency features in the diagnosis of severity of fatty liver disease
by: Zhixiang Wang, et al.
Published: (2025-06-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective
by: Yan Chen, et al.
Published: (2025-07-01)

Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment
by: Hee Yeon Kim, et al.
Published: (2025-07-01)

Histones post-translational modifications associated with the development of metabolic dysfunction-associated fatty liver disease. Part 3. Histon acetylation
by: O.E. Abaturov, et al.
Published: (2025-03-01)

Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation
by: Jieun Choi, et al.
Published: (2025-12-01)

Update of machine learning for ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a bright future for deep learning
by: Jiawen Li, et al.
Published: (2025-06-01)

Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus
by: Toru Suzuki, et al.
Published: (2025-07-01)

Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Fatty Acid Metabolism
by: Han F, et al.
Published: (2025-05-01)

From cooperation to collapse: systemic failure in liver disease through a sociological lens
by: Junyu Wang, et al.
Published: (2025-07-01)

Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
by: Shengyu Zhang, et al.
Published: (2025-06-01)

Correlation Between Lipid Accumulation Product and Metabolic Dysfunction-Associated Steatotic Liver Disease in Chinese Adults with Type 2 Diabetes Mellitus
by: Liu W, et al.
Published: (2025-06-01)

Non-invasive methods for diagnosing portal hypertension and variceal bleeding due to liver cirrhosis secondary to NAFLD/MASLD: systematic review
by: Nebyu Yonas Shanka, et al.
Published: (2025-01-01)

Cognitive dysfunction in patients with non-alcoholic fatty liver disease
by: S. A. Smakotina, et al.
Published: (2025-06-01)

Crosstalk between Epigenetics and Autophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Irfana Zahoor, et al.
Published: (2025-07-01)

Association of Serum Selenium with Clinical Features and Inflammatory and Oxidative Stress Markers in Iranian Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease—A Cross-Sectional Study
by: Abbas Pishdadian, et al.
Published: (2025-06-01)

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
by: Hye Won Lee, et al.
Published: (2025-07-01)

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
by: Lampros Chrysavgis, et al.
Published: (2025-06-01)

Association of Metabolic Dysfunction‐Associated Steatotic Liver Disease With Sudden Sensorineural Hearing Loss Among Older Adults
by: Eun Seok Kang, et al.
Published: (2025-06-01)

Current and Emerging Treatments for Metabolic Associated Steatotic Liver Disease and Diabetes: A Narrative Review
by: Rachelle Choi, et al.
Published: (2025-06-01)

Probiotics as a therapeutic strategy for metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
by: Jing Lu, et al.
Published: (2025-01-01)